.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
McKesson
Baxter
Federal Trade Commission
Mallinckrodt
QuintilesIMS
Moodys
Accenture
Queensland Health

Generated: June 25, 2017

DrugPatentWatch Database Preview

Doxorubicin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxorubicin hydrochloride and what is the scope of doxorubicin hydrochloride freedom to operate?

Doxorubicin hydrochloride
is the generic ingredient in five branded drugs marketed by Mylan Labs Ltd, Alvogen Inc, Janssen Res And Dev, Sun Pharm Inds, West-ward Pharms Int, Actavis Inc, Bristol Myers Squibb, Pharmacia And Upjohn, Pharmachemie Bv, Teva Pharms Usa, Sandoz Inc, Dr Reddys Labs Ltd, Sun Pharma Global, Fresenius Kabi Usa, Amneal Pharms Co, and Sagent Pharms, and is included in twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for doxorubicin hydrochloride. Fourteen suppliers are listed for this compound.

Summary for Generic Name: doxorubicin hydrochloride

Tradenames:5
Patents:1
Applicants:16
NDAs:22
Drug Master File Entries: see list17
Suppliers / Packagers: see list14
Bulk Api Vendors: see list76
Clinical Trials: see list3,445
Patent Applications: see list9,176
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxorubicin hydrochloride at DailyMed

Pharmacology for Ingredient: doxorubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION050629-002May 3, 1988APRXYesYes► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-002May 21, 1990APRXNoNo► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063336-004Feb 28, 1995APRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION208657-002May 15, 2017ABRXNoNo► Subscribe► Subscribe
Amneal Pharms Co
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION208888-002Feb 17, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: doxorubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-002Jun 13, 20005,213,804► Subscribe
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-001Nov 17, 19955,013,556► Subscribe
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-002Jun 13, 20005,013,556► Subscribe
Janssen Res And Dev
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION050718-001Nov 17, 19955,213,804► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Colorcon
Julphar
UBS
US Army
Queensland Health
McKinsey
Deloitte
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot